FindTrial
Sign In

carboplatin and paclitaxel

DRUG10 trials

Sponsors

Eisai Inc., Rigshospitalet, Denmark, The Netherlands Cancer Institute, Danish Gynecological Cancer Group, Korean Gynecologic Oncology Group

Conditions

Breast CancerEndometrial CancerEndometrial CarcinomaFallopian TubeFallopian Tube CancerHigh Grade Serous OvarianLocally Advanced Head and Neck Squamous Cell CarcinomaNeoplasms, Endometrial

Phase 1

A Study of Carboplatin and Paclitaxel Chemotherapy With Nivolumab With or Without Ipilimumab in Patients With Ovarian Cancer
CompletedNCT03245892
Memorial Sloan Kettering Cancer CenterFallopian Tube, High Grade Serous Ovarian, Primary Peritoneal Cancer
Start: 2017-08-04End: 2025-12-04Updated: 2025-12-17

Phase 2

Neo Adjuvant Chemotherapy in Triple Negative Breast Cancer
Active, not recruitingNCT01057069
The Netherlands Cancer InstituteBreast Cancer
Start: 2010-01-31End: 2029-12-31Updated: 2022-10-12
Chemotherapy or Observation in Stage I-II Intermediate or High Risk Endometrial Cancer
Active, not recruitingNCT01244789
Danish Gynecological Cancer GroupEndometrial Cancer
Start: 2011-12-01End: 2028-07-01Updated: 2026-04-13
A Phase IIclinical Trial of Carboplatin and Paclitaxel or Carboplatin and Gemcitabine in Platinum-sensitive, Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
NCT01570582
Korean Gynecologic Oncology GroupFallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cancer
Start: 2010-03-31End: 2014-03-31Target: 314Updated: 2012-04-04
Adjuvant Sequential & Concurrent CarboTaxol + Radiotherapy for High Risk Endometrial Cancer
NCT03935256
Loyola UniversityEndometrial Cancer
Start: 2019-03-05End: 2024-12-31Target: 24Updated: 2023-12-18
The UPPROACH (Upfront Intensity Modulated Proton Beam Therapy) Approach
TerminatedNCT04527900
University of Maryland, BaltimoreEndometrial Cancer
Start: 2021-02-23End: 2024-07-02Updated: 2026-07-08
Study of RP3 in Combination With Nivolumab and Other Therapy in Patients With Locoregionally Advanced or Recurrent SCCHN
WithdrawnNCT05743270
Replimune Inc.Locally Advanced Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma, Squamous Cell Carcinoma of Head and Neck
Start: 2024-01-30End: 2026-06-01Updated: 2025-03-11

Phase 3

Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer
CompletedNCT00050960
Eisai Inc.Non-small Cell Lung Cancer
Start: 2002-05-31End: 2005-03-31Updated: 2012-07-13
Neoadjuvant Chemotherapy in Non Small Cell Lung Cancer (NSCLC) Stages IB, IIA, IIB, and IIIA/T3
TerminatedNCT00273507
Rigshospitalet, DenmarkNon-small Cell Lung Cancer
Start: 1998-01-31End: 2006-01-31Target: 270Updated: 2009-09-18
Two Part (Phase1b/ Phase3) Trial of Subcutaneous Dostarlimab Plus Carboplatin-Paclitaxel in Participants With Primary Advanced or Recurrent Endometrial Cancer
Not yet recruitingNCT07860450
GlaxoSmithKlineEndometrial Carcinoma, Neoplasms, Endometrial
Start: 2026-11-12End: 2032-11-05Target: 378Updated: 2026-10-19

Related Papers

A pilot study of nivolumab in combination with neoadjuvant and post-surgical chemotherapy in newly diagnosed ovarian cancer.
2025-10-31
High-dose alkylating chemotherapy in BRCA-altered triple-negative breast cancer: the randomized phase III NeoTN trial.
2023-09-095 citations
A phase 2, open-label, multicenter study investigating efficacy and safety of RP3 oncolytic immunotherapy combined with other therapies in patients with locoregionally advanced or recurrent squamous cell carcinoma of the head and neck.
Journal of Clinical Oncology2023-06-012 citations
Postoperative chemotherapy or no further treatment for patients with node-negative stage I-II intermediate or high risk endometrial cancer: The ENGOT-EN2/DGCG trial.
Journal of Clinical Oncology2017-05-207 citations
Decisions on Further Research for Predictive Biomarkers of High-Dose Alkylating Chemotherapy in Triple-Negative Breast Cancer: A Value of Information Analysis.
2016-04-0611 citations
Early stage cost-effectiveness analysis of a BRCA1-like test to detect triple negative breast cancers responsive to high dose alkylating chemotherapy.
2015-04-289 citations
Phase 3 Trial to Compare Postoperative Chemotherapy with Observation in Stage I or II Endometrial Cancer
MD Conference Express2014-11-01
A phase III trial of postoperative chemotherapy or no further treatment for patients with node-negative stage I-II intermediate- or high-risk endometrial cancer. ENGOT-EN2-DGCG/EORTC 55102.
Journal of Clinical Oncology2014-05-202 citations